Profile of pridopidine and its potential in the treatment of Huntington disease: the evidence to date
Ferdinando Squitieri,1 Justo Garcia de Yebenes2 1IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo and Mendel Institute of Human Genetics, Rome, Italy; 2Fundación para Investigaciones Neurológicas, Madrid, Spain Abstract: Huntington disease (HD) is a chronic, genetic...
Main Authors: | Squitieri F, de Yebenes JG |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-10-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | https://www.dovepress.com/profile-of-pridopidine-and-its-potential-in-the-treatment-of-huntingto-peer-reviewed-article-DDDT |
Similar Items
-
Profile of netupitant/palonosetron (NEPA) fixed dose combination and its potential in the treatment of chemotherapy-induced nausea and vomiting (CINV)
by: Navari RM
Published: (2014-12-01) -
Implantable inlay devices for presbyopia: the evidence to date
by: Arlt EM, et al.
Published: (2015-01-01) -
Nose-to-Brain Delivery by Nanosuspensions-Based in situ Gel for Breviscapine
by: Chen Y, et al.
Published: (2020-12-01) -
Patient-reported treatment satisfaction and choice of dosing frequency with biologic treatment for moderate to severe plaque psoriasis
by: Zhang M, et al.
Published: (2015-06-01) -
Laser Profilometry Aiding Smart Vehicle Control
by: Cosimo Patruno, et al.
Published: (2014-12-01)